Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Pulmatrix Inc

PULM ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$1.51

▲ +0.00%

Market Cap $5.62M · Vol 2.29K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$5.62M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

28.05

Momentum

Beta

1.81

vs Market

52W High

$5.45

72.29% below

52W Low

$1.18

27.97% above

Volume

2.29K

Avg 3.63K

P/B

2.14

Price-to-book

ROE

N/A

Return on equity

Free Float

99.23%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Pulmatrix Inc (PULM) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PULM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-8.48%

-6.79%

+18.90%

-37.86%

YTD

-32.29%

-69.49%

-39.84%

-90.32%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-5,162,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-73.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	2.14
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	3.65M

Technical Indicators

50-Day SMA	$1.60
200-Day SMA	$2.34
RSI (14)	28.05
Beta	1.81
52-Week High	$5.45
52-Week Low	$1.18

Volume Today	2.29K
Avg Daily Volume (30D)	3.63K
Relative Volume	0.63x
Volatility (10D)	32.96
Volatility (30D)	51.74
Free Float	99.23%

Analyst Consensus

N/A

Current Price $1.51

Mean Target N/A

52W Low$1.18 52W High$5.45

Current

Target

$1.18 $5.45

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG003TH2QM0

ISINUS74584P3010

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Pulmatrix, Inc. is a biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with unmet medical needs using its patented iSPERSE technology. The Company’s proprietary product pipeline includes treatments for central nervous system (CNS) disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) and allergic bronchopulmonary aspergillosis (ABPA). Pulmatrix’s product candidates are based on its proprietary engineered dry powder delivery platform, iSPERSE, which seeks to enhance therapeutic delivery to the lungs by optimizing pharmacokinetics and reducing systemic side effects to improve patient outcomes. iSPERSE is a proprietary technology that allows a broad range of drugs to be formulated as small, dense, and dispersible particles for efficient drug delivery and deep penetration into the lungs.